More research is needed to determine the best approach to monitoring and managing these patients once the medication is discontinued. According to Maya and colleagues, current evidence on links between GLP-1s and pregnancy complications remain limited, conflicting and subject to residual confounding by indication or selection and recall bias. They added that if gestational weight gain is a result of GLP-1 discontinuation before or early during pregnancy, negative outcomes for the parent-child dyad could result. In the retrospective analysis, the researchers assessed outcomes among 149,790 singleton pregnancies delivered between June 1, 2016, and March 31, 2025
While there are theoretical potentials for Semaglutide to influence serotonin and dopamine levels, studies indicate it does not significantly affect the efficacy of selective serotonin reuptake inhibitors in depressed patients
The ABCs of solute carriers: Physiological, pathological and therapeutic implications of human membrane transport proteins: Introduction
The settlement covered conduct between January 1, 2016 and June 20, 2021